Mesoblast
MESO
#4331
Rank
A$3.63 B
Marketcap
A$28.26
Share price
3.59%
Change (1 day)
67.83%
Change (1 year)

Mesoblast (MESO) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : A$0.28 Billion

According to Mesoblast 's latest financial reports the company's total liabilities are A$0.28 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Mesoblast - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-06-30A$0.28 B12.5%
2023-06-30A$0.25 B5.06%
2022-06-30A$0.23 B9.88%
2021-06-30A$0.21 B-18.41%
2020-06-30A$0.26 B9.62%
2019-06-30A$0.24 B23.13%
2018-06-30A$0.19 B9.32%
2017-06-30A$0.18 B-13.52%
2016-06-30A$0.20 B-48.69%
2015-06-30A$0.40 B17.39%
2014-06-30A$0.34 B25.14%
2013-06-30A$0.27 B17.69%
2012-06-30A$0.23 B2.19%
2011-06-30A$0.23 B12154.48%
2010-06-30A$1.88 M28.59%
2009-06-30A$1.46 M-10.92%
2008-06-30A$1.64 M99.24%
2007-06-30A$0.82 M-86.38%
2006-06-30A$6.05 M109.89%
2005-06-30A$2.88 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NRC Health
NRC
A$0.18 B-35.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
A$4.74 M-98.32% Bahamas